Understanding the Benefits of Harnessing Just in Time Manufacturing as a Supply Chain Solution for Managed Access Programs
Challenges that can prevent sponsors realizing the full potential of managed access programs can be overcome by embracing a just-in-time manufacturing strategy.
Drug Solutions Podcast: Realizing AI’s Potential
This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.
Roche Introduces New Mass Spectrometry Analyzer
The launch of Roche's cobas mass spectrometry solution will bring fully automated mass spec analysis to the clinical lab.
Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends
In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.
Prasinezumab Misses Primary Endpoint in Roche’s Phase IIb Study, but Has Potential in Treating Early Stage Parkinson’s Disease
Results from a Phase IIb study missed the primary endpoint by failing to achieve statistical significance.
Innovation, Collaboration, and Performance Were Highlights for EMA in 2024
Emer Cooke, executive director of EMA, is encouraged by the competitiveness of the European pharmaceutical market.
